Details for New Drug Application (NDA): 062739
✉ Email this page to a colleague
NDA 062739 describes TAZIDIME IN PLASTIC CONTAINER, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the TAZIDIME IN PLASTIC CONTAINER profile page.
The generic ingredient in TAZIDIME IN PLASTIC CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
The generic ingredient in TAZIDIME IN PLASTIC CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Summary for 062739
| Tradename: | TAZIDIME IN PLASTIC CONTAINER |
| Applicant: | Lilly |
| Ingredient: | ceftazidime |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062739
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/VIAL | ||||
| Approval Date: | Jul 10, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/VIAL | ||||
| Approval Date: | Jul 10, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
